Sermorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) consisting of 29 amino acids, representing the biologically active fragment of endogenous GHRH. It has attracted growing interest in research focused on growth hormone deficiency, anti-aging, and metabolic health.
Studies have shown that Sermorelin stimulates endogenous growth hormone secretion from the pituitary gland by binding to GHRH receptors, leading to increased insulin-like growth factor-1 (IGF-1) levels. It promotes protein synthesis, fat metabolism, and tissue repair. It may also play a role in sleep quality improvement, muscle mass preservation, bone density enhancement, and recovery from age-related decline.
GHRH receptor activation and GH/IGF-1 axis stimulation
Muscle mass preservation and protein synthesis
Fat metabolism and weight management
Bone density and connective tissue health
Anti-aging and age-related hormone decline research